TCG Crossover Management, LLC Diversified Active

CIK: 0001839948 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value ($000): $1,180,307 (100.0% shares, 0.0% debt)

Holdings (36)

CGON CG ONCOLOGY, INC. 11.7%
Value ($000) $138,477 Shares 3,670,206 Est. Cost $40.67 Unrealized -13.8%
DYN DYNE THERAPEUTICS, INC 8.1%
Value ($000) $95,193 Shares 2,650,150 Est. Cost $16.62 Unrealized +139.5%
COGT COGENT BIOSCIENCES INC 6.4%
Value ($000) $75,215 Shares 6,964,375 Est. Cost $9.05 Unrealized +7.6%
ABVX Abivax SA 5.9%
Value ($000) $69,772 Shares 6,056,596 Est. Cost $12.76 Unrealized
EWTX EDGEWISE THERAPEUTICS, INC. 4.8%
Value ($000) $56,396 Shares 2,112,984 Est. Cost $15.89 Unrealized +25.2%
SLN SILENCE THERAPEUTICS PLC 4.7%
Value ($000) $55,150 Shares 3,033,560 Est. Cost $14.21 Unrealized
SVRA SAVARA INC. 4.4%
Value ($000) $52,416 Shares 12,362,205 Est. Cost $3.73 Unrealized +18.3%
KROS KEROS THERAPEUTICS, INC. 4.3%
Value ($000) $51,064 Shares 879,344 Est. Cost $59.30 Unrealized -16.7%
XNCR XENCOR INC 4.1%
Value ($000) $48,810 Shares 2,427,138 Est. Cost $18.77 Unrealized 0.0%
TYRA TYRA BIOSCIENCES INC 4.0%
Value ($000) $46,764 Shares 1,989,103 Est. Cost $12.71 Unrealized +65.2%
GPCR STRUCTURE THERAPEUTICS INC 4.0%
Value ($000) $46,655 Shares 1,063,000 Est. Cost $43.45 Unrealized
OCUL OCULAR THERAPEUTIX, INC. 3.9%
Value ($000) $46,277 Shares 5,319,148 Est. Cost $7.10 Unrealized +16.1%
CNTA CENTESSA PHARMACEUTICALS PLC 3.9%
Value ($000) $46,224 Shares 2,890,816 Est. Cost $7.22 Unrealized
TOURMALINE BIO INC 3.2%
Value ($000) $37,989 Shares 1,477,593 Est. Cost $25.14 Unrealized
THIRD HARMONIC BIO INC 2.8%
Value ($000) $32,723 Shares 2,415,000 Est. Cost $13.55 Unrealized
ASTRIA THERAPEUTICS, INC. 2.6%
Value ($000) $30,408 Shares 2,761,861 Est. Cost $14.07 Unrealized
MLYS MINERALYS THERAPEUTICS, INC. 2.5%
Value ($000) $29,915 Shares 2,470,265 Est. Cost $12.35 Unrealized -2.0%
KURA KURA ONCOLOGY INC 2.4%
Value ($000) $27,818 Shares 1,423,642 Est. Cost $14.54 Unrealized +39.3%
SLNO SOLENO THERAPEUTIVS, INC. 2.4%
Value ($000) $27,770 Shares 550,000 Est. Cost $47.87 Unrealized 0.0%
CMPS COMPASS PATHWAYS PLC 2.1%
Value ($000) $24,305 Shares 3,858,000 Est. Cost $7.40 Unrealized
IRON Disc Medicine, Inc. 2.0%
Value ($000) $23,929 Shares 486,957 Est. Cost $33.98 Unrealized +38.2%
FULC FULCRUM THERAPEUTICS INC 1.6%
Value ($000) $18,743 Shares 5,250,000 Est. Cost $7.42 Unrealized 0.0%
MBX MBX BIOSCIENCES INC 1.4%
Value ($000) $16,887 Shares 650,000 Est. Cost $22.87 Unrealized 0.0%
AMLX AMYLYX PHARMACEUTICALS INC 1.3%
Value ($000) $15,046 Shares 4,643,812 Est. Cost $2.25 Unrealized 0.0%
ADVERUM BIOTECHNOLOGIES, INC. 1.2%
Value ($000) $14,099 Shares 2,008,339 Est. Cost $7.02 Unrealized
TRDA ENTRADA THERAPEUTICS INC 0.8%
Value ($000) $9,348 Shares 584,955 Est. Cost $17.12 Unrealized
VTGN VISTAGEN THERAPEUTICS INC 0.7%
Value ($000) $8,057 Shares 2,676,580 Est. Cost $3.41 Unrealized 0.0%
TARS TARSUS PHARMACEUTICALS, INC. 0.6%
Value ($000) $7,625 Shares 231,820 Est. Cost $17.70 Unrealized +58.8%
EYPT EyePoint Pharmaceuticals, Inc. 0.6%
Value ($000) $7,369 Shares 922,335 Est. Cost $13.97 Unrealized -37.1%
NEKTAR THERAPEUTICS 0.4%
Value ($000) $5,200 Shares 4,000,000 Est. Cost $0.93 Unrealized
AEROVATE THERAPEUTICS INC 0.4%
Value ($000) $4,683 Shares 2,240,809 Est. Cost $15.50 Unrealized
AVTX AVALO THERAPEUTICS INC 0.4%
Value ($000) $4,589 Shares 483,000 Est. Cost $10.31 Unrealized 0.0%
KOD KODIAK SCIENCES INC 0.2%
Value ($000) $2,631 Shares 1,008,158 Est. Cost $3.95 Unrealized -32.7%
ANTX AN2 Therapeutics, Inc. 0.1%
Value ($000) $1,664 Shares 1,555,118 Est. Cost $9.33 Unrealized -81.4%
VTYX VENTYX BIOSCIENCES, INC 0.1%
Value ($000) $689 Shares 316,195 Est. Cost $29.94 Unrealized -92.3%
CABA CABALETTA BIO, INC 0.0%
Value ($000) $410 Shares 86,795 Est. Cost $3.64 Unrealized +58.9%